These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17601991

  • 1. A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells.
    Riedl E, Koeppel H, Brinkkoetter P, Sternik P, Steinbeisser H, Sauerhoefer S, Janssen B, van der Woude FJ, Yard BA.
    Diabetes; 2007 Sep; 56(9):2410-3. PubMed ID: 17601991
    [Abstract] [Full Text] [Related]

  • 2. Association of CTG repeat polymorphism in carnosine dipeptidase 1 (CNDP1) gene with diabetic nephropathy in north Indians.
    Yadav AK, Sinha N, Kumar V, Bhansali A, Dutta P, Jha V.
    Indian J Med Res; 2016 Jul; 144(1):32-37. PubMed ID: 27834323
    [Abstract] [Full Text] [Related]

  • 3. Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans.
    Everaert I, Taes Y, De Heer E, Baelde H, Zutinic A, Yard B, Sauerhöfer S, Vanhee L, Delanghe J, Aldini G, Derave W.
    Am J Physiol Renal Physiol; 2012 Jun 15; 302(12):F1537-44. PubMed ID: 22496410
    [Abstract] [Full Text] [Related]

  • 4. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.
    McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW.
    Hum Genet; 2009 Aug 15; 126(2):265-75. PubMed ID: 19373489
    [Abstract] [Full Text] [Related]

  • 5. Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathy.
    Zhang S, Albrecht T, Rodriguez-Niño A, Qiu J, Schnuelle P, Peters V, Schmitt CP, van den Born J, Bakker SJL, Lammert A, Krämer BK, Yard BA, Hauske SJ.
    Amino Acids; 2019 Apr 15; 51(4):611-617. PubMed ID: 30610469
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese.
    Mooyaart AL, van Valkengoed IG, Shaw PK, Peters V, Baelde HJ, Rabelink TJ, Bruijn JA, Stronks K, de Heer E.
    Diabetes Res Clin Pract; 2009 Sep 15; 85(3):272-8. PubMed ID: 19577318
    [Abstract] [Full Text] [Related]

  • 9. Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
    Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS.
    Diabetes; 2008 Sep 15; 57(9):2547-51. PubMed ID: 18753673
    [Abstract] [Full Text] [Related]

  • 10. The CNDP1 (CTG)5 Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration.
    Albrecht T, Zhang S, Braun JD, Xia L, Rodriquez A, Qiu J, Peters V, Schmitt CP, van den Born J, Bakker SJL, Lammert A, Köppel H, Schnuelle P, Krämer BK, Yard BA, Hauske SJ.
    J Diabetes Res; 2017 Sep 15; 2017():9506730. PubMed ID: 28553654
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. N-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia.
    Riedl E, Koeppel H, Pfister F, Peters V, Sauerhoefer S, Sternik P, Brinkkoetter P, Zentgraf H, Navis G, Henning RH, Van Den Born J, Bakker SJ, Janssen B, van der Woude FJ, Yard BA.
    Diabetes; 2010 Aug 15; 59(8):1984-90. PubMed ID: 20460427
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Re: Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
    Bakker SJ, Alkhalaf A, Tarnow L, Navis G.
    Diabetes; 2008 Dec 15; 57(12):e16; author reply e17. PubMed ID: 19033401
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.
    Alkhalaf A, Bakker SJ, Bilo HJ, Gans RO, Navis GJ, Postmus D, Forsblom C, Groop PH, Vionnet N, Hadjadj S, Marre M, Parving HH, Rossing P, Tarnow L.
    Diabetologia; 2010 Dec 15; 53(12):2562-8. PubMed ID: 20711718
    [Abstract] [Full Text] [Related]

  • 18. Vegetarianism, female gender and increasing age, but not CNDP1 genotype, are associated with reduced muscle carnosine levels in humans.
    Everaert I, Mooyaart A, Baguet A, Zutinic A, Baelde H, Achten E, Taes Y, De Heer E, Derave W.
    Amino Acids; 2011 Apr 15; 40(4):1221-9. PubMed ID: 20865290
    [Abstract] [Full Text] [Related]

  • 19. Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians.
    Chakkera HA, Hanson RL, Kobes S, Millis MP, Nelson RG, Knowler WC, Distefano JK.
    Mol Genet Metab; 2011 Jun 15; 103(2):185-90. PubMed ID: 21393041
    [Abstract] [Full Text] [Related]

  • 20. Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with type 2 diabetes (ZODIAC-22).
    Alkhalaf A, Landman GW, van Hateren KJ, Groenier KH, Mooyaart AL, De Heer E, Gans RO, Navis GJ, Bakker SJ, Kleefstra N, Bilo HJ.
    J Nephrol; 2015 Apr 15; 28(2):201-7. PubMed ID: 24756973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.